Hi @Ragnarolf
There have been some replies to your post, but I'm not sure anyone clarified that the trial-in-progress poster presentation for the nextHERIZON trial was published at the ASCO GI conference in January. An oral presentation and poster for the HERIZON trial were also published.
There presentations are listed on Imugene's website under the Conference Presentations and a link to the trial-in-progress poster for nextHERIZON is provided here for your convenience:
PowerPoint Presentation (squarespace.com) - "nextHERIZON: A PHASE 2 STUDY OF HER-VAXX, A HER-2 TARGETING PEPTIDE VACCINE, IN
COMBINATION WITH CHEMOTHERAPY OR PEMBROLIZUMAB IN PATIENTS WITH HER-2 METASTATIC OR ADVANCED GASTRIC/GASTROESOPHAGEAL ADENOCARCINOMA WHO PROGRESSED ON OR AFTER
TRASTUZUMAB TREATMENT"
Note that no new data was published for nextHERIZON and so, per the Investor Presentation you referenced, the next milestone for nextHERIZON will be an interim data readout, some time later this year perhaps.
Hope this helps.
- Forums
- ASX - By Stock
- Hervaxx Trials
Hi @Ragnarolf There have been some replies to your post, but I'm...
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $404.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.6¢ | 5.4¢ | $757.1K | 13.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2203877 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 244428 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2203877 | 0.054 |
24 | 3523105 | 0.053 |
21 | 1966792 | 0.052 |
18 | 1595967 | 0.051 |
64 | 5239130 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 244428 | 4 |
0.056 | 606122 | 6 |
0.057 | 1272468 | 9 |
0.058 | 419109 | 6 |
0.059 | 475000 | 4 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |